0001225208-22-011291.txt : 20221102 0001225208-22-011291.hdr.sgml : 20221102 20221102170314 ACCESSION NUMBER: 0001225208-22-011291 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20221031 FILED AS OF DATE: 20221102 DATE AS OF CHANGE: 20221102 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Calio Christopher T. CENTRAL INDEX KEY: 0001781357 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-00812 FILM NUMBER: 221355085 MAIL ADDRESS: STREET 1: 870 WINTER STREET CITY: WALTHAM STATE: MA ZIP: 02451 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: RAYTHEON TECHNOLOGIES CORP CENTRAL INDEX KEY: 0000101829 STANDARD INDUSTRIAL CLASSIFICATION: AIRCRAFT ENGINES & ENGINE PARTS [3724] IRS NUMBER: 060570975 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 870 WINTER STREET CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: 781-522-3000 MAIL ADDRESS: STREET 1: 870 WINTER STREET CITY: WALTHAM STATE: MA ZIP: 02451 FORMER COMPANY: FORMER CONFORMED NAME: UNITED TECHNOLOGIES CORP /DE/ DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: UNITED TECHNOLOGIES MICROELECTRONICS CENTER DATE OF NAME CHANGE: 19850825 FORMER COMPANY: FORMER CONFORMED NAME: UNITED TECHNOLOGIES CORP DATE OF NAME CHANGE: 19841205 4 1 doc4.xml X0306 4 2022-10-31 0000101829 RAYTHEON TECHNOLOGIES CORP RTX 0001781357 Calio Christopher T. 1000 WILSON BLVD. ARLINGTON VA 22209 1 Chief Operating Officer Common Stock 2022-10-31 4 M 0 5022.0000 62.4100 A 46259.0000 D Common Stock 2022-10-31 4 S 0 1697.0000 94.2560 D 44562.0000 D Common Stock 2022-10-31 4 D 0 3325.0000 94.2400 D 41237.0000 D Common Stock 3816.0000 I By Savings Plan Trustee Stock Appreciation Right 62.4100 2022-10-31 4 M 0 5022.0000 0.0000 D 2016-01-02 2023-01-01 Common Stock 5022.0000 0.0000 D The Stock Appreciation Rights (SARs) were settled in shares in accordance with the terms of the award. For Section 16 reporting purposes, the exercise of SARs for stock is treated as an exempt acquisition of the shares underlying the SARs at the exercise price per share specified in the award of SARs and a simultaneous sale back to the issuer of a number of the underlying shares having a value, based on the market price of the issuer's stock on the date of the exercise, equal to the product of the number of underlying SARs times the exercise price per share. /s/ Dana Ng as Attorney-In-Fact 2022-11-02